advertisement
Craig JE 69
Showing records 1 to 25 | Display all abstracts from Craig JE106636 Cost-effectiveness of polygenic risk profiling for primary open-angle glaucoma in the United Kingdom and Australia
Liu Q
Eye 2023; 37: 2335-2343
106309 Association of High Polygenic Risk With Visual Field Worsening Despite Treatment in Early Primary Open-Angle Glaucoma
Siggs OM
JAMA ophthalmology 2022; 141: 73-77
106183 Attitudes Toward Glaucoma Genetic Risk Assessment in Unaffected Individuals
Hollitt GL
Translational vision science & technology 2022; 11: 38
106544 Thrombospondin 1 missense alleles induce extracellular matrix protein aggregation and TM dysfunction in congenital glaucoma
Fu H
Journal of Clinical Investigation 2022; 132:
106147 The phenotypic spectrum of associated ectopia lentis: Additional cases, complications, and review of literature
Knight LSW
Molecular Vision 2022; 28: 257-268
105995 Specifications of the ACMG/AMP variant curation guidelines for myocilin: Recommendations from the clingen glaucoma expert panel
Burdon KP
Human Mutation 2022; 43: 2170-2186
106309 Association of High Polygenic Risk With Visual Field Worsening Despite Treatment in Early Primary Open-Angle Glaucoma
Qassim A
JAMA ophthalmology 2022; 141: 73-77
105995 Specifications of the ACMG/AMP variant curation guidelines for myocilin: Recommendations from the clingen glaucoma expert panel
Graham P
Human Mutation 2022; 43: 2170-2186
106636 Cost-effectiveness of polygenic risk profiling for primary open-angle glaucoma in the United Kingdom and Australia
Davis J
Eye 2023; 37: 2335-2343
106183 Attitudes Toward Glaucoma Genetic Risk Assessment in Unaffected Individuals
Siggs OM
Translational vision science & technology 2022; 11: 38
106147 The phenotypic spectrum of associated ectopia lentis: Additional cases, complications, and review of literature
Mullany S
Molecular Vision 2022; 28: 257-268
106544 Thrombospondin 1 missense alleles induce extracellular matrix protein aggregation and TM dysfunction in congenital glaucoma
Siggs OM
Journal of Clinical Investigation 2022; 132:
106636 Cost-effectiveness of polygenic risk profiling for primary open-angle glaucoma in the United Kingdom and Australia
Han X
Eye 2023; 37: 2335-2343
105995 Specifications of the ACMG/AMP variant curation guidelines for myocilin: Recommendations from the clingen glaucoma expert panel
Hadler J
Human Mutation 2022; 43: 2170-2186
106309 Association of High Polygenic Risk With Visual Field Worsening Despite Treatment in Early Primary Open-Angle Glaucoma
Han X
JAMA ophthalmology 2022; 141: 73-77
106544 Thrombospondin 1 missense alleles induce extracellular matrix protein aggregation and TM dysfunction in congenital glaucoma
Knight LS
Journal of Clinical Investigation 2022; 132:
106147 The phenotypic spectrum of associated ectopia lentis: Additional cases, complications, and review of literature
Taranath DA
Molecular Vision 2022; 28: 257-268
106183 Attitudes Toward Glaucoma Genetic Risk Assessment in Unaffected Individuals
Ridge B
Translational vision science & technology 2022; 11: 38
105995 Specifications of the ACMG/AMP variant curation guidelines for myocilin: Recommendations from the clingen glaucoma expert panel
Hulleman JD
Human Mutation 2022; 43: 2170-2186
106309 Association of High Polygenic Risk With Visual Field Worsening Despite Treatment in Early Primary Open-Angle Glaucoma
Marshall HN
JAMA ophthalmology 2022; 141: 73-77
106147 The phenotypic spectrum of associated ectopia lentis: Additional cases, complications, and review of literature
Ruddle JB
Molecular Vision 2022; 28: 257-268
106183 Attitudes Toward Glaucoma Genetic Risk Assessment in Unaffected Individuals
Keane MC
Translational vision science & technology 2022; 11: 38
106636 Cost-effectiveness of polygenic risk profiling for primary open-angle glaucoma in the United Kingdom and Australia
Mackey DA
Eye 2023; 37: 2335-2343
106544 Thrombospondin 1 missense alleles induce extracellular matrix protein aggregation and TM dysfunction in congenital glaucoma
Staffieri SE
Journal of Clinical Investigation 2022; 132:
106183 Attitudes Toward Glaucoma Genetic Risk Assessment in Unaffected Individuals
Mackey DA
Translational vision science & technology 2022; 11: 38